MAY 16, 2008 3:26pm ET

Related Links

eHealth Initiative Studies the I.T. of ACOs
February 10, 2012
CSC Report Looks Ahead to Stage 2 Meaningful Use
February 7, 2012
Survey: Shifts May be Coming in CMIO Demographics
February 6, 2012
Survey: Docs Love Mobile Devices, I.T. Departments Don’t
February 3, 2012
Survey: U.S. and Foreign Docs Differ on Many I.T. Benefits
January 26, 2012
Hospital CEOs Outline Challenges in a New World
January 24, 2012
New Name, COO for MedQuist
January 24, 2012

Web Seminars

Ensuring Operational Excellence and Enhanced Patient Safety in your Hospital through Mobile and Wireless Technology
Available On Demand
The Evolution of Tablet Computing in Healthcare
Available On Demand
Medicine in Motion: How Desktop Virtualization is Changing the Game
Available On Demand

VeriChip Looking to Sell

Print
Reprints
Email

Radio frequency identification technology vendor VeriChip Corp. is selling one part of the company and may eventually sell all of it.

The Delray Beach, Fla.-based vendor will sell its Xmark Corp. subsidiary for $45 million to The Stanley Works, a New Britain, Conn.-based manufacturer of tools and security products. Xmark sells RFID technology to tag and track newborns and persons prone to wandering and to track medical equipment.

VeriChip will use the proceeds to retire all outstanding debt and to fund a special dividend to shareholders of at least $15 million. The company has approximately 11 million common shares outstanding. VeriChip went public in February 2007 at $6.50 per share; the stock closed May 15 at $2.27.

VeriChip CEO and Chair Scott Silverman and the board have mutually agreed that he will leave those positions at the closing of the Xmark sale but will remain as a consultant in the sale of remaining assets. The company also sells implantable chips to track human remains in a disaster and markets vibration monitoring equipment.

The company has retained an investment banking firm to assist in selling the VeriMed Health Link business line of implantable RFID identification chips. A small number of people have had the chips implanted. The chips contain information on how to access their electronic medical records in an emergency, but a hospital must have a VeriChip-supplied reader. Some Alzheimers’ patients also have had the chip implanted to combat wandering. The company is developing an implantable chip to measure glucose levels.

VeriChip is selling Xmark because as a public company, it received an offer it could not refuse, says Jay McKeage, vice president of corporate development. The company is looking to sell VeriMed because the unit is funded by Xmark and is not self-sustaining. “It’s much better with someone who can take it on board and further develop it,” he adds. McKeage would not comment on the reasons for Silverman’s departure.

During the first quarter of 2008, VeriChip had a net loss of $2.8 million, compared with a $3.3 million loss during the same period last year. Quarterly revenue rose 21% to $8.6 million. More information is available at verichipcorp.com.

Comments (0)

Be the first to comment on this post using the section below.

Add Your Comments:
You must be registered to post a comment.
Not Registered?
You must be registered to post a comment. Click here to register.
Already registered? Log in here
Please note you must now log in with your email address and password.
Twitter
Facebook
LinkedIn

A major success factor for accountable care organizations will be linking caregivers across the spectrum of care delivery. If history is any indication, that's going to be an industrywide struggle.

Login  |  My Account  |  White Papers  |  Web Seminars  |  Events |  Newsletters |  eBooks
FOLLOW US
Already a subscriber? Log in here
Please note you must now log in with your email address and password.